GL1X · GenesisL1 explorer

MolNFT v1 · #98616 · protein

Ctx-M-9 in complex with the broad spectrum inhibitor 3-(2- CARBOXYVINYL)BENZO(B)THIOPHENE-2-boronic acid

4LEN · Beta-lactamase: “Ctx-M-9 in complex with the broad spectrum inhibitor 3-(2- CARBOXYVINYL)BENZO(B)THIOPHENE-2-boronic acid”. X-ray diffraction, 1 ligand (2GK), 2 pockets (best druggability 0.33). MolNFT v1 #98616 on GenesisL1: 3D…

PDB
4LEN
Type
protein
Length
524 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q9L5C8
Ligands
2GK
Pockets
2 · best druggability 0.33

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein26343% helix, 19% strandQ9L5C8
BBeta-lactamase (EC 3.5.2.6)protein26144% helix, 20% strandQ9L5C8

Ligands and binding sites

  • 2GK · (2E)-3-[2-(dihydroxyboranyl)-1-benzothiophen-3-yl]prop-2-enoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1860.330.75212GK
2730.300.74192GK

Interfaces

1 interface between chains.

  • A–B · 139 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 4LEN · CTX-M-9 in complex with the broad spectrum inhibitor 3-(2… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.